Federal Register Notice: FDA’s collection of information, Guidance for Industry on Continuous Marketing Applications: Pilot — Scientific Feedback and Interactions During Development of Fast Track Products Under the Prescription Drug User Fee Act, has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. To view this notice, click here.